| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| fn-1501 | cyclin-dependent kinase 2 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 1 | unknown |
| fn-1501 | cyclin-dependent kinase 4 | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 1 | unknown |
| fn-1501 | cyclin-dependent kinase 6 | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 1 | unknown |
| fn-1501 | fms-like tyrosine kinase 3 | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||